Biochemistry: Investigation Observed Value Unit Biological Reference Interval
Biochemistry: Investigation Observed Value Unit Biological Reference Interval
Biochemistry: Investigation Observed Value Unit Biological Reference Interval
ASHUTOSH KUMAR
PID No. : IND97503 Register On : 31/12/2020 9:36 AM
SID No. : 420078189 Collection On : 31/12/2020 10:31 AM
Age / Sex : 43 Year(s) / Male Report On : 31/12/2020 7:01 PM
Type : OP Printed On : 31/12/2020 7:08 PM
MC-3113
Ref. Dr : DR. SELF
INTERPRETATION: Factors such as type, quantity and time of food intake, Physical activity, Psychological stress, and drugs can influence
blood glucose level.
Glucose Postprandial (PPBS) 311 mg/dL < 140
(Plasma - PP/GOD - POD)
INTERPRETATION: Factors such as type, quantity and time of food intake, Physical activity, Psychological stress, and drugs can influence
blood glucose level. Fasting blood glucose level may be higher than Postprandial glucose, because of physiological surge in Postprandial
Insulin secretion, Insulin resistance, Dawn Phenomenon, Somogyi Phenomenon, Anti- diabetic medication during treatment for Diabetes.
Urea 15 mg/dL 15 - 45
(Serum/Urease-GLDH/UV)
INTERPRETATION: About 85% of urea is eliminated via kidneys; the rest is excreted via the gastrointestinal (GI) tract. Serum urea is
increased when renal clearance decreased (in acute and chronic renal failure/impairment). Urea may also increase in other conditions not
related to renal diseases such as upper GI bleeding, dehydration, catabolic states, and high protein diets. Urea may be decreased in starvation,
low-protein diet, and severe liver disease.
Creatinine 0.9 mg/dL 0.9 - 1.3
(Serum/Modified Jaffe)
2 0 6
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
APPROVED BY
INTERPRETATION: The reference ranges are based on fasting condition. Triglyceride levels change drastically in response to food,
increasing as much as 5 to 10 times the fasting levels, just a few hours after eating. Fasting triglyceride levels show considerable diurnal
variation too. There is evidence recommending triglycerides estimation in non-fasting condition for evaluating the risk of heart disease and
screening for metabolic syndrome, as non-fasting sample is more representative of the ³usual´circulating level of triglycerides during most
part of the day.
HDL Cholesterol 55 mg/dL Optimal(Negative Risk Factor): >= 60
(Serum/Immunoinhibition) Borderline: 40 - 59
High Risk: < 40
2 0 8
APPROVED BY
INTERPRETATION: 1.Non-HDL Cholesterol is now proven to be a better cardiovascular risk marker than LDL Cholesterol.
2.It is the sum of all potentially atherogenic proteins including LDL, IDL, VLDL and chylomicrons and it is the "new bad cholesterol" and is a
co-primary target for cholesterol lowering therapy.
Total Cholesterol/HDL Cholesterol Ratio 4 Optimal: < 3.3
(Serum/Calculated) Low Risk: 3.4 - 4.4
Average Risk: 4.5 - 7.1
Moderate Risk: 7.2 - 11.0
High Risk: > 11.0
2 0 8
APPROVED BY
PHYSICAL EXAMINATION
APPROVED BY
APPROVED BY
1 1 19
APPROVED BY
-- End of Report --
INTERPRETATION: Detection Limit :3.8-18.5%. Conditions that prolong RBC life span like Iron deficiency anemia, Vitamin B12 & Folate
deficiency, hypertriglyceridemia, hyperbilirubinemia, Drugs, Alcohol, Lead Poisoning, Asplenia can give falsely elevated HbA1C values.
Conditions that shorten RBC survival like acute or chronic blood loss, hemolytic anemia, Hemoglobinopathies, Splenomegaly, Vitamin E
ingestion, Pregnancy, End stage Renal disease can cause falsely low HbA1c. HbA1C measurement is not appropriate when there has been a
change in diet or treatment within 6 weeks.
Estimated Average Glucose 300.57 mg/dL 85 - 150
(Blood)
2 0 2
-- End of Report --
Page 1 of 1
VERIFIED BY
APPROVED BY